| abstract |
A 2,6-dinitrogen-containing substituted purine compound represented by the structural formula (A), or a salt thereof, or a solvate thereof, or a solvate of a salt thereof, and a drug combination containing them. provide. The compound of the present invention has advantages such as low toxicity, wide anti-cancer width, high anti-cancer activity and good stability. It can be used for the manufacture of antitumor drugs. In addition, the manufacturing method of the said compound is disclosed by this invention. [Selection figure] None |